Cardinal Health's Revenue by Segment
In fiscal year 2025, Cardinal Health's revenue by segment (products & services) are as follows:
- GMPD: $12.64 B
- Other Operating Segment: $5.38 B
- Pharmaceutical Member: $204.64 B
Learn more about Cardinal Health’s Revenue by Geography
Check out competitors to Cardinal Health in a side-by-side comparison.
Explore additional financial metrics for Cardinal Health.
Cardinal Health's Revenue Share by Segment
| Cardinal Health At Home Solutions | 2640000000 |
|---|---|
| Medical Member | 12374000000 |
| Nuclear Precision Health Services | 1197000000 |
| Pharmaceutical Member | 188812000000 |
| GMPD | 12381000000 |
|---|---|
| Other Operating Segment | 4512000000 |
| Pharmaceutical Member | 210019000000 |
| GMPD | 12636000000 |
|---|---|
| Other Operating Segment | 5382000000 |
| Pharmaceutical Member | 204644000000 |
The above chart shows Cardinal Health's revenue percentage share by segment (products and services).
In fiscal year 2023, Cardinal Health's revenue by segment is as follows:
- Cardinal Health At Home Solutions generated $2.64 B in revenue, representing 1.29% of its total revenue.
- Medical Member generated $12.37 B in revenue, representing 6.04% of its total revenue.
- Nuclear Precision Health Services generated $1.20 B in revenue, representing 0.58% of its total revenue.
- Pharmaceutical Member generated $188.81 B in revenue, representing 92.09% of its total revenue.
The biggest segment for Cardinal Health is the Pharmaceutical Member, which represents 92.09% of its total revenue.
The smallest segment for Cardinal Health is the Nuclear Precision Health Services, which represents 0.58% of its total revenue.
The above chart shows Cardinal Health's revenue percentage share by segment (products and services).
In fiscal year 2024, Cardinal Health's revenue by segment is as follows:
- GMPD generated $12.38 B in revenue, representing 5.46% of its total revenue.
- Other Operating Segment generated $4.51 B in revenue, representing 1.99% of its total revenue.
- Pharmaceutical Member generated $210.02 B in revenue, representing 92.56% of its total revenue.
The biggest segment for Cardinal Health is the Pharmaceutical Member, which represents 92.56% of its total revenue.
The smallest segment for Cardinal Health is the Other Operating Segment, which represents 1.99% of its total revenue.
The above chart shows Cardinal Health's revenue percentage share by segment (products and services).
In fiscal year 2025, Cardinal Health's revenue by segment is as follows:
- GMPD generated $12.64 B in revenue, representing 5.67% of its total revenue.
- Other Operating Segment generated $5.38 B in revenue, representing 2.42% of its total revenue.
- Pharmaceutical Member generated $204.64 B in revenue, representing 91.91% of its total revenue.
The biggest segment for Cardinal Health is the Pharmaceutical Member, which represents 91.91% of its total revenue.
The smallest segment for Cardinal Health is the Other Operating Segment, which represents 2.42% of its total revenue.
Summary Table
| Products & Services (Percent Share) | 2023 | 2024 | 2025 |
|---|---|---|---|
| Cardinal Health At Home Solutions | 1.29% | - | - |
| Medical Member | 6.04% | - | - |
| Nuclear Precision Health Services | 0.58% | - | - |
| Pharmaceutical Member | 92.09% | 92.56% | 91.91% |
| GMPD | - | 5.46% | 5.67% |
| Other Operating Segment | - | 1.99% | 2.42% |
| Total Revenue | 100% | 100% | 100% |
Cardinal Health's Segments Revenue Trend
The above chart shows the revenue trend of different segments of Cardinal Health.
In fiscal year 2025, the Pharmaceutical Member generated the most revenue ($204.64 B), and the Other Operating Segment generated the least revenue ($5.38 B).
Cardinal Health's Revenue Growth Drivers
The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.
Summary Table
| Products & Services | 2023 | 2024 | 2025 |
|---|---|---|---|
| Cardinal Health At Home Solutions | $2.64 B - | - - | - - |
| GMPD | - - | $12.38 B - |
$12.64 B
2.06%
|
| Medical Member | $12.37 B - | - - | - - |
| Nuclear Precision Health Services | $1.20 B - | - - | - - |
| Other Operating Segment | - - | $4.51 B - |
$5.38 B
19.28%
|
| Pharmaceutical Member | $188.81 B - |
$210.02 B
11.23%
|
$204.64 B
2.56%
|
| Total Revenue | $205.02 B - |
$226.91 B
10.68%
|
$222.66 B
1.87%
|
Related
-
Agilent Technologies Revenue by Segment
-
Eli Lilly and Company Revenue by Segment
-
Stryker Corporation Revenue by Segment
-
Johnson & Johnson Revenue by Segment
-
AbbVie Revenue by Segment
-
Merck & Co. Revenue by Segment
-
Thermo Fisher Scientific Revenue by Segment
-
Abbott Laboratories Revenue by Segment
-
Danaher Corporation Revenue by Segment
-
Amgen Revenue by Segment
